ZLAB — Zai Lab Ltd
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1704292 ·
China
Last close
$25.64
Market Cap
$2.88B
52W High
$27.50
52W Low
$16.26
ADV30
1,041,209
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 106,311,000 | 58,149,000 | -76,489,000 | -50,825,000 | 1,074,793,000 | 607,522,000 | 467,756,000 |
| Mar 2026 | 99,611,000 | 61,276,000 | -69,279,000 | -51,016,000 | 1,095,737,000 | 651,316,000 | 433,756,000 |
| Dec 2025 | 127,597,000 | 65,266,000 | -68,264,000 | -50,409,000 | 1,172,384,000 | 679,573,000 | 456,884,000 |
| Sep 2025 | 116,095,000 | 69,212,000 | -47,968,000 | -35,963,000 | 1,158,940,000 | 717,155,000 | 398,995,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-133,384,000
Investing CF
$-39,050,000
Financing CF
$44,641,000
CapEx
$-29,134,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.80
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-2,730,461,000
Inventory
$90,890,000
Receivables
$72,990,000
ST Investments
$10,000,000
EBIT TTM
$-184,737,000
Pretax Income TTM
$-190,722,000
Interest Exp TTM
$5,985,000
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$449,614,016
EBITDA
$-248,168,000
Free Cash Flow
$-83,963,752
Enterprise Value
$2,515,560,192
Total Cash
$617,521,984
Total Debt
$254,576,000
Shares Out
112,266,228
Trailing EPS
$-1.70
Book Value
$5.96
ROE
-26.9%
ROA
-14.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 460,156,000 | -223,572,000 | -175,537,000 | 1,172,384,000 | 456,884,000 | — | -150,789,000 |
| Dec 2024 | 398,988,000 | -273,947,000 | -257,103,000 | 1,185,753,000 | 344,855,000 | — | -214,869,000 |
| Dec 2023 | 266,719,000 | -374,140,000 | -334,620,000 | 1,036,295,000 | 240,177,000 | — | -198,178,000 |
| Dec 2022 | 215,040,000 | -392,886,000 | -443,286,000 | 1,220,140,000 | 174,545,000 | — | -367,642,000 |
TTM Snapshot
Revenues TTM
$102,265,000
NetIncome TTM
$-41,671,000
OpCashFlow TTM
$0
Assets (Latest)
$1,185,753,000
Forward EPS
$-2.06
Max Pain — expiry 2026-12-18
max pain strike: $22.50 · spot: $25.64 · call oi: 362 · put oi: 2,744
Expected Move to 2026-12-18:
±$11.05
(43.10%) —
implied range
$14.59 –
$36.69
· ATM straddle on $25.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SLS | SELLAS Life Sciences Group, Inc. | $2.89B | $14.32 | — |
| ALMS | ALUMIS INC. | $2.98B | $23.03 | — |
| ATAI | AtaiBeckley Inc. | $2.74B | $7.38 | — |
| NRIX | Nurix Therapeutics, Inc. | $2.73B | $26.27 | — |
| VRDN | Viridian Therapeutics, Inc.\DE | $2.72B | $24.02 | — |
News headlines (Yahoo Finance, 1h cache)
Global DLL3 Targeted Therapies Market 2026-2030: Profiles Amgen, Zai Lab, Boehringer Ingelheim and Phanes Therapeutics
2026-08-20 15:30 · Yahoo
Coultreon Biopharma Appoints Prista Charuworn, MD as Chief Medical Officer
2026-08-18 07:00 · Yahoo
Zai Lab (ZLAB) Q2 2026 Earnings Call Transcript
2026-08-13 13:58 · Yahoo
Asian Equities Traded in the US as American Depositary Receipts Marginally Higher in Thursday Trading
2026-08-13 14:44 · Yahoo
Could argenx SE (ARGX)’s Global Scale Give it an Edge Over Zai Lab Limited American Depositary Shares (ZLAB)?
2026-08-20 22:27 · Yahoo
Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Wednesday Trading
2026-08-19 14:46 · Yahoo
Zai Lab and argenx Announce Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis
2026-08-17 10:00 · Yahoo
Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading
2026-08-11 14:43 · Yahoo
Is Zai Lab’s (ZLAB) Rising Loss on Softer Revenue Reframing Its Investment-Led Growth Story?
2026-08-10 02:08 · Yahoo
Zai Lab (ZLAB) Rebounds Following Earnings While Its Undervalued Narrative Faces A Fresh Test
2026-08-09 17:09 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.